LENZ Therapeutics (LENZ) had the highest return between January 6, 2024 and May 7, 2024 by a small-cap US stock, returning 768%.
| ASSET | DATE | % RETURN |
|---|---|---|
LENZ Therapeutics (LENZ) | 1/6/2024 - 5/7/2024 | 767.98% |
Janux Therapeutics (JANX) | 1/6/2024 - 5/7/2024 | 500.59% |
Mesoblast (MESO) | 1/6/2024 - 5/7/2024 | 282.45% |
Sonida Senior Living (SNDA) | 1/6/2024 - 5/7/2024 | 254.51% |
TSS, Inc Common Stock (TSSI) | 1/6/2024 - 5/7/2024 | 230.58% |
Rezolute (RZLT) | 1/6/2024 - 5/7/2024 | 200.75% |
Cullinan Oncology LLC (CGEM) | 1/6/2024 - 5/7/2024 | 190.88% |
Real Brokerage (REAX) | 1/6/2024 - 5/7/2024 | 188.7% |
CytomX Therapeutics (CTMX) | 1/6/2024 - 5/7/2024 | 171.33% |
Benitec Biopharma Ltd ADR (BNTC) | 1/6/2024 - 5/7/2024 | 157.1% |
Niagen Bioscience (NAGE) | 1/6/2024 - 5/7/2024 | 153.38% |
CuriosityStream (CURIW) | 1/6/2024 - 5/7/2024 | 150% |
Intuitive Machines (LUNR) | 1/6/2024 - 5/7/2024 | 145.11% |
Curiositystream (CURI) | 1/6/2024 - 5/7/2024 | 143% |
ADC Therapeutics (ADCT) | 1/6/2024 - 5/7/2024 | 137.93% |
Byrna Technologies (BYRN) | 1/6/2024 - 5/7/2024 | 133.79% |
Mind Medicine (MNMD) | 1/6/2024 - 5/7/2024 | 131.23% |
Stoke Therapeutics (STOK) | 1/6/2024 - 5/7/2024 | 130.5% |
KULR Technology (KULR) | 1/6/2024 - 5/7/2024 | 127.11% |
GH Research (GHRS) | 1/6/2024 - 5/7/2024 | 126.64% |
EverQuote Inc Class A (EVER) | 1/6/2024 - 5/7/2024 | 123.41% |
Sweetgreen (SG) | 1/6/2024 - 5/7/2024 | 123.13% |
POET Technologies (POET) | 1/6/2024 - 5/7/2024 | 122.34% |
Trevi Therapeutics (TRVI) | 1/6/2024 - 5/7/2024 | 119.7% |
Hippo (HIPO) | 1/6/2024 - 5/7/2024 | 115.83% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
